WO2006026592A3 - Oral administration of poorly absorbed drugs, methods and compositions related thereto - Google Patents

Oral administration of poorly absorbed drugs, methods and compositions related thereto Download PDF

Info

Publication number
WO2006026592A3
WO2006026592A3 PCT/US2005/030774 US2005030774W WO2006026592A3 WO 2006026592 A3 WO2006026592 A3 WO 2006026592A3 US 2005030774 W US2005030774 W US 2005030774W WO 2006026592 A3 WO2006026592 A3 WO 2006026592A3
Authority
WO
Grant status
Application
Patent type
Prior art keywords
drug
poorly absorbed
absorbed drugs
methods
oral administration
Prior art date
Application number
PCT/US2005/030774
Other languages
French (fr)
Other versions
WO2006026592A2 (en )
Inventor
Edith Mathiowitz
Avinash Nangia
Jules S Jacob
Mark R Kreitz
Rebecca Doane
Ryan Donnelly
Original Assignee
Spherics Inc
Edith Mathiowitz
Avinash Nangia
Jules S Jacob
Mark R Kreitz
Rebecca Doane
Ryan Donnelly
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51Nanocapsules; Nanoparticles
    • A61K9/5107Excipients; Inactive ingredients
    • A61K9/513Organic macromolecular compounds; Dendrimers
    • A61K9/5138Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51Nanocapsules; Nanoparticles
    • A61K9/5107Excipients; Inactive ingredients
    • A61K9/513Organic macromolecular compounds; Dendrimers
    • A61K9/5146Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51Nanocapsules; Nanoparticles
    • A61K9/5107Excipients; Inactive ingredients
    • A61K9/513Organic macromolecular compounds; Dendrimers
    • A61K9/5161Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51Nanocapsules; Nanoparticles
    • A61K9/5192Processes

Abstract

The invention provides methods and compositions for the delivery of poorly absorbed drugs. In some embodiments, the drug is administered in the form of microparticles or nanoparticles. In other embodiments, the drug is encapsulated with polymer. In certain embodiments, the drug is administered in combination with an absorption enhancer. The invention further relates to dosing schedules to maintain the oral bioavailability of poorly absorbed drugs, such as paclitaxel. In another embodiment, the method involves administering inhibitors of one or more inhibitors of a drug efflux pump in combination with a poorly absorbed drug.
PCT/US2005/030774 2003-12-09 2005-08-29 Oral administration of poorly absorbed drugs, methods and compositions related thereto WO2006026592A3 (en)

Priority Applications (26)

Application Number Priority Date Filing Date Title
US60520004 true 2004-08-27 2004-08-27
US60520104 true 2004-08-27 2004-08-27
US60499004 true 2004-08-27 2004-08-27
US60519904 true 2004-08-27 2004-08-27
US60499104 true 2004-08-27 2004-08-27
US60519804 true 2004-08-27 2004-08-27
US60/605,199 2004-08-27
US60/604,990 2004-08-27
US60/605,198 2004-08-27
US60/605,200 2004-08-27
US60/605,201 2004-08-27
US60/604,991 2004-08-27
US60790504 true 2004-09-08 2004-09-08
US60/607,905 2004-09-08
US11009327 US20050201974A1 (en) 2003-12-09 2004-12-09 Bioadhesive polymers with catechol functionality
US11/009,327 2004-12-09
US63581204 true 2004-12-13 2004-12-13
US60/635,812 2004-12-13
US65019105 true 2005-02-04 2005-02-04
US65037505 true 2005-02-04 2005-02-04
US60/650,191 2005-02-04
US60/650,375 2005-02-04
US11072098 US20050249799A1 (en) 2004-03-03 2005-03-03 Polymeric drug delivery system for hydrophobic drugs
US11/072,098 2005-03-03
US67638305 true 2005-04-29 2005-04-29
US60/676,383 2005-04-29

Publications (2)

Publication Number Publication Date
WO2006026592A2 true WO2006026592A2 (en) 2006-03-09
WO2006026592A3 true true WO2006026592A3 (en) 2006-09-14

Family

ID=35703588

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/030774 WO2006026592A3 (en) 2003-12-09 2005-08-29 Oral administration of poorly absorbed drugs, methods and compositions related thereto

Country Status (1)

Country Link
WO (1) WO2006026592A3 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8911777B2 (en) 2007-04-04 2014-12-16 Sigmoid Pharma Limited Pharmaceutical composition of tacrolimus
US8951570B2 (en) 2007-04-26 2015-02-10 Sigmoid Pharma Limited Manufacture of multiple minicapsules
CN105101950A (en) * 2013-03-05 2015-11-25 安特里斯生物制药公司 Pharmaceuticals for oral delivery
US9220681B2 (en) 2012-07-05 2015-12-29 Sigmoid Pharma Limited Formulations
US9278070B2 (en) 2009-05-18 2016-03-08 Sigmoid Pharma Limited Composition comprising oil drops

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070077309A1 (en) * 2005-09-30 2007-04-05 Wong Patrick S Banded controlled release nanoparticle active agent formulation dosage forms and methods
US20100239665A1 (en) * 2007-05-01 2010-09-23 Ivan Coulter Pharmaceutical nimodipine compositions
JP5537425B2 (en) 2007-06-26 2014-07-02 メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. Lyophilized antifungal composition
US9089544B2 (en) 2007-08-24 2015-07-28 Slotervaart Participaties Bv Composition
KR101544498B1 (en) * 2007-08-24 2015-08-17 스티칭 허트 네덜란드 칸커 인스티튜트 Compositions for the treatment of neoplastic diseases
WO2011018504A3 (en) 2009-08-12 2011-06-23 Sigmoid Pharma Limited Immunomodulatory compositions comprising a polymer matrix and an oil phase
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
US9833411B2 (en) 2015-01-12 2017-12-05 Enteris Biopharma, Inc. Solid oral dosage forms

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6228399B1 (en) * 1996-08-22 2001-05-08 Research Triangle Pharmaceuticals Composition and method of preparing microparticles of water-insoluble substances
US6322817B1 (en) * 1999-02-17 2001-11-27 Dabur Research Foundation Formulations of paclitaxel, its derivatives or its analogs entrapped into nanoparticles of polymeric micelles, process for preparing same and the use thereof
US20020013271A1 (en) * 1996-08-22 2002-01-31 Indu Parikh Cyclosporiine particles
US6391335B1 (en) * 1998-04-29 2002-05-21 Cima Labs Inc. Effervescent drug delivery system for oral administration
US6537579B1 (en) * 1993-02-22 2003-03-25 American Bioscience, Inc. Compositions and methods for administration of pharmacologically active compounds

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6537579B1 (en) * 1993-02-22 2003-03-25 American Bioscience, Inc. Compositions and methods for administration of pharmacologically active compounds
US6228399B1 (en) * 1996-08-22 2001-05-08 Research Triangle Pharmaceuticals Composition and method of preparing microparticles of water-insoluble substances
US20020013271A1 (en) * 1996-08-22 2002-01-31 Indu Parikh Cyclosporiine particles
US6391335B1 (en) * 1998-04-29 2002-05-21 Cima Labs Inc. Effervescent drug delivery system for oral administration
US6322817B1 (en) * 1999-02-17 2001-11-27 Dabur Research Foundation Formulations of paclitaxel, its derivatives or its analogs entrapped into nanoparticles of polymeric micelles, process for preparing same and the use thereof

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8911777B2 (en) 2007-04-04 2014-12-16 Sigmoid Pharma Limited Pharmaceutical composition of tacrolimus
US9114071B2 (en) 2007-04-04 2015-08-25 Sigmoid Pharma Limited Oral pharmaceutical composition
US9387179B2 (en) 2007-04-04 2016-07-12 Sigmoid Pharma Limited Pharmaceutical cyclosporin compositions
US9585844B2 (en) 2007-04-04 2017-03-07 Sigmoid Pharma Limited Oral pharmaceutical composition
US8951570B2 (en) 2007-04-26 2015-02-10 Sigmoid Pharma Limited Manufacture of multiple minicapsules
US9402788B2 (en) 2007-04-26 2016-08-02 Sigmoid Pharma Limited Manufacture of multiple minicapsules
US9278070B2 (en) 2009-05-18 2016-03-08 Sigmoid Pharma Limited Composition comprising oil drops
US9220681B2 (en) 2012-07-05 2015-12-29 Sigmoid Pharma Limited Formulations
CN105101950A (en) * 2013-03-05 2015-11-25 安特里斯生物制药公司 Pharmaceuticals for oral delivery

Also Published As

Publication number Publication date Type
WO2006026592A2 (en) 2006-03-09 application

Similar Documents

Publication Publication Date Title
Ünlügenç et al. A comparative study on the analgesic effect of tramadol, tramadol plus magnesium, and tramadol plus ketamine for postoperative pain management after major abdominal surgery
WO2005070332A1 (en) Long-term delivery formulations and methods of use thereof
WO2000041693A2 (en) Compositions having improved delivery of actives
US20090258865A1 (en) Administration of benzodiazepine compositions
WO2007130491A3 (en) Patient customized therapeutic regimens
Saif et al. Phase II clinical trial of paclitaxel loaded polymeric micelle in patients with advanced pancreatic cancer
US20100034880A1 (en) Pharmaceutical compositions based on a microemulsion
WO2007027941A3 (en) Compositions and methods for preparation of poorly water soluble drugs with increased stability
CN1969818A (en) Anticancer sustained release injection containing epothilone derivatives
CN101396340A (en) Anti-cancer sustained-released injection containing epothilone derivate
WO2002051380A1 (en) Novel pharmaceutical composition consisting of water-soluble or poorly water-soluble active substances
WO2005050526A8 (en) System for maintaining drug information and communicating with medication delivery devices
Reddy et al. Drug delivery design for intravenous route with integrated physicochemistry, pharmacokinetics and pharmacodynamics: illustration with the case of taxane therapeutics
WO2006022996A3 (en) Dosage form containing multiple drugs
Yeum et al. Effect of naringin pretreatment on bioavailability of verapamil in rabbits
WO2008027350A3 (en) Acetaminophen pharmaceutical compositions
Lu et al. Sucrose acetate isobutyrate as an in situ forming system for sustained risperidone release
WO2004105782A3 (en) Drug delivery systems for tumor targeting ngr-molecules and uses thereof
WO2008025790A3 (en) Use of opioid formulations in needle-less drug delivery devices
Park et al. Long-acting injectable formulations of antipsychotic drugs for the treatment of schizophrenia
Wang et al. Design of a long-term antipsychotic in situ forming implant and its release control method and mechanism
WO2005112886A3 (en) Methods and articles for the delivery of therapeutic agents
Beiranvand et al. New updates pertaining to drug delivery of local anesthetics in particular bupivacaine using lipid nanoparticles
Lawson et al. Current developments in intraspinal agents for cancer and noncancer pain
RU2220740C1 (en) Agent for treatment of allergic rhinitis and allergic conjunctivitis

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct application non-entry in european phase